{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:01:02Z","timestamp":1790719262255,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,3,17]],"date-time":"2013-03-17T00:00:00Z","timestamp":1363478400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s11739-013-0929-7","type":"journal-article","created":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T10:05:09Z","timestamp":1363428309000},"page":"397-403","source":"Crossref","is-referenced-by-count":14,"title":["Does decreased fibrinolysis have a role to play in the development of non-neoplastic portal vein thrombosis in patients with hepatic cirrhosis?"],"prefix":"10.1007","volume":"9","author":[{"given":"Valeria","family":"Rossetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Spiezia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Senzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krissia Isabel","family":"Rodriguez-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Gavasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Woodhams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Simioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,17]]},"reference":[{"key":"929_CR1","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/hep.21303","volume":"44","author":"SH Caldwell","year":"2006","unstructured":"Caldwell SH, Hoffman M, Lisman T, Macik BG, Northup PG, Reddy KR, Tripodi A, Sanyal AJ (2006) Coagulation in Liver Disease Group. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology 44:1039\u20131046","journal-title":"Hepatology"},{"key":"929_CR2","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1053\/j.gastro.2009.08.045","volume":"137","author":"A Tripodi","year":"2009","unstructured":"Tripodi A, Primignani M, Chantarangkul V, Dell\u2019Era A, Clerici M, de Franchis R, Colombo M, Mannucci PM (2009) An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology 137:2105\u20132111","journal-title":"Gastroenterology"},{"key":"929_CR3","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1538-7836.2008.03018.x","volume":"6","author":"A Tripodi","year":"2008","unstructured":"Tripodi A, Legnani C, Chantarangkul V, Cosmi B, Palareti G, Mannucci PM (2008) High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism. J Thromb Haemost 6:1327\u20131333","journal-title":"J Thromb Haemost"},{"key":"929_CR4","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jhep.2008.12.020","volume":"50","author":"I Martinelli","year":"2009","unstructured":"Martinelli I, Primignani M, Aghemo A, Reati R, Bucciarelli P, Fabris F, Battaglioli T, Dell\u2019Era A, Mannucci PM (2009) High levels of factor VIII and risk of extra-hepatic portal vein obstruction. J Hepatol 50:916\u2013922","journal-title":"J Hepatol"},{"key":"929_CR5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ajg.2008.34","volume":"104","author":"KK S\u00f8gaard","year":"2009","unstructured":"S\u00f8gaard KK, Horv\u00e1th-Puh\u00f3 E, Gr\u00f8nbaek H, Jepsen P, Vilstrup H, S\u00f8rensen HT (2009) Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case\u2013control study. Am J Gastroenterol 104:96\u2013101","journal-title":"Am J Gastroenterol"},{"key":"929_CR6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1055\/s-2002-33210","volume":"34","author":"L Amitrano","year":"2002","unstructured":"Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Sacco M, Martino R, De Nucci C, Mosca S, Iannaccone L, Ames PR, Romano L, Balzano A (2002) Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: role of genetic thrombophilia. Endoscopy 34:535\u2013538","journal-title":"Endoscopy"},{"key":"929_CR7","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00042737-200507000-00009","volume":"17","author":"A Mangia","year":"2005","unstructured":"Mangia A, Villani MR, Cappucci G, Santoro R, Ricciardi R, Facciorusso D, Leandro G, Caruso N, Andriulli A (2005) Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol 17:745\u2013751","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"929_CR8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep.510310307","volume":"31","author":"MH Denninger","year":"2000","unstructured":"Denninger MH, Cha\u00eft Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, Erlinger S, Briere J, Valla D (2000) Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 31:587\u2013591","journal-title":"Hepatology"},{"key":"929_CR9","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2004.01.001","volume":"40","author":"L Amitrano","year":"2004","unstructured":"Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, Grandone E, Balzano A (2004) Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 40:736\u2013741","journal-title":"J Hepatol"},{"key":"929_CR10","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/jcp.24.9.822","volume":"24","author":"D Ogston","year":"1971","unstructured":"Ogston D, Bennett B, Ogston CM (1971) The fibrinolytic enzyme system in hepatic cirrhosis and malignant metastases. J Clin Pathol 24:822\u2013826","journal-title":"J Clin Pathol"},{"key":"929_CR11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0049-3848(91)90022-O","volume":"62","author":"K Huber","year":"1991","unstructured":"Huber K, Kirchheimer JC, Korninger C, Binder BR (1991) Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteers and in patients with different stages of liver cirrhosis. Thromb Res 62:491\u2013500","journal-title":"Thromb Res"},{"key":"929_CR12","first-page":"54354","volume":"75","author":"AJ Simpson","year":"1990","unstructured":"Simpson AJ, Booth NA, Moore N, Bennett B (1990) The platelet and plasma pools of plasminogen activator inhibitor (PAI-1) vary independently in disease. Br J Haematol 75:54354\u201354358","journal-title":"Br J Haematol"},{"key":"929_CR13","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0895-4356(03)00052-0","volume":"56","author":"AR Folsom","year":"2003","unstructured":"Folsom AR, Cushman M, Heckbert SR, Rosamond WD, Aleksic N (2003) Prospective study of fibrinolytic markers and venous thromboembolism. J Clin Epidemiol 56:598\u2013603","journal-title":"J Clin Epidemiol"},{"key":"929_CR14","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/archinte.1991.00400090023006","volume":"151","author":"MH Prins","year":"1991","unstructured":"Prins MH, Hirsh J (1991) A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism. Arch Intern Med 151:1721\u20131731","journal-title":"Arch Intern Med"},{"key":"929_CR15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood-2010-02-267740","volume":"116","author":"ME Meltzer","year":"2010","unstructured":"Meltzer ME, Lisman T, de Groot PG, Meijers JC, le Cessie S, Doggen CJ, Rosendaal FR (2010) Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1. Blood 116:113\u2013121","journal-title":"Blood"},{"key":"929_CR16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/blood-2009-03-211557","volume":"115","author":"J Hoekstra","year":"2010","unstructured":"Hoekstra J, Guimar\u00e3es AH, Leebeek FW, DarwishMurad S, Malfliet JJ, Plessier A et al (2010) European Network for Vascular Disorders of the Liver (EN-Vie). Impaired fibrinolysis as a risk factor for Budd\u2013Chiari syndrome. Blood 115:388\u2013395","journal-title":"Blood"},{"key":"929_CR17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ajh.10192","volume":"71","author":"G Balta","year":"2002","unstructured":"Balta G, Altay C, Gurgey A (2002) PAI-1 gene 4G\/5G genotype: a risk factor for thrombosis in vessels of internal organs. Am J Hematol 71:89\u201393","journal-title":"Am J Hematol"},{"key":"929_CR18","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1111\/j.1572-0241.1999.01446.x","volume":"94","author":"Z Ben-Ari","year":"1999","unstructured":"Ben-Ari Z, Osman E, Hutton RA, Burroughs AK (1999) Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? Am J Gastroenterol 94:2977\u20132982","journal-title":"Am J Gastroenterol"},{"key":"929_CR19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/s-2007-994024","volume":"19","author":"JA Paramo","year":"1993","unstructured":"Paramo JA, Rocha E (1993) Hemostasis in advanced liver disease. Semin Thromb Hemost 19:184\u2013190","journal-title":"Semin Thromb Hemost"},{"key":"929_CR20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2141.1989.tb06276.x","volume":"71","author":"JT Wilde","year":"1989","unstructured":"Wilde JT, Kitchen S, Kinsey S, Greaves M, Preston FE (1989) Plasma-D-dimer levels and their relationship to serum fibrinogen\/fibrin degradation products in hypercoagulable states. Br J Haematol 71:65\u201370","journal-title":"Br J Haematol"},{"key":"929_CR21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0049-3848(95)91614-Q","volume":"77","author":"T Vukovich","year":"1995","unstructured":"Vukovich T, Teufelsbauer H, Fritzer M, Kreuzer S, Knoflach P (1995) Hemostasis activation in patients with liver cirrhosis. Thromb Res 77:271\u2013278","journal-title":"Thromb Res"},{"key":"929_CR22","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/jhep.2003.50277","volume":"38","author":"M Colucci","year":"2003","unstructured":"Colucci M, Binetti BM, Branca MG, Clerici C, Morelli A, Semeraro N, Gresele P (2003) Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis. Hepatology 38:230\u2013237","journal-title":"Hepatology"},{"key":"929_CR23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/gast.2001.25481","volume":"121","author":"T Lisman","year":"2001","unstructured":"Lisman T, Leebeek FW, Mosnier LO, Bouma BN, Meijers JC, Janssen HL, Nieuwenhuis HK, De Groot PG (2001) Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology 121:131\u2013139","journal-title":"Gastroenterology"},{"key":"929_CR24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11739-009-0302-z","volume":"5","author":"A Tripodi","year":"2010","unstructured":"Tripodi A, Primignani M, Mannucci PM (2010) Abnormalities of hemostasis and bleeding in chronic liver disease: the paradigm is challenged. Intern Emerg Med 5:7\u201312","journal-title":"Intern Emerg Med"},{"key":"929_CR25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000083832","volume":"33","author":"BN Bouma","year":"2003","unstructured":"Bouma BN, Mosnier LO (2003) Thrombin activatable fibrinolysis inhibitor (TAFI) at the interface between coagulation and fibrinolysis. Pathophysiol Haemost Thromb 33:375\u2013381","journal-title":"Pathophysiol Haemost Thromb"},{"key":"929_CR26","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1161\/01.ATV.20.12.2511","volume":"20","author":"L Bajzar","year":"2000","unstructured":"Bajzar L (2000) Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway. Arterioscler Thromb Vasc Biol 20:2511\u20132518","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"929_CR27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1074\/jbc.271.2.603","volume":"271","author":"L Bajzar","year":"1996","unstructured":"Bajzar L, Morser J, Nesheim M (1996) TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombinthrombomodulin complex. J Biol Chem 271:603\u2013608","journal-title":"J Biol Chem"},{"key":"929_CR28","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/s-0038-1657557","volume":"78","author":"M Nesheim","year":"1997","unstructured":"Nesheim M, Wang W, Boffa M, Nagashima M, Morser J, Bajzar L (1997) Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb Haemost 78:386\u2013391","journal-title":"Thromb Haemost"},{"key":"929_CR29","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1182\/blood.V95.9.2855.009k02_2855_2859","volume":"95","author":"NH Tilburg Van","year":"2000","unstructured":"Van Tilburg NH, Rosendaal FR, Bertina RM (2000) Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis. Blood 95:2855\u20132859","journal-title":"Blood"},{"key":"929_CR30","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1182\/blood-2003-06-2169","volume":"103","author":"M Colucci","year":"2004","unstructured":"Colucci M, Binetti BM, Tripodi A, Chantarangkul V, Semeraro N (2004) Hyperthrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism. Blood 103:2157\u20132161","journal-title":"Blood"},{"key":"929_CR31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/ijlh.12003","volume":"35","author":"V Rossetto","year":"2012","unstructured":"Rossetto V, Spiezia L, Senzolo M, Rodriguez K, Gavasso S, Woodhams B, Simioni P (2012) Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosis. Int J Lab Hematol 35:101\u2013105","journal-title":"Int J Lab Hematol"},{"key":"929_CR32","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RN Pugh","year":"1973","unstructured":"Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646\u2013649","journal-title":"Br J Surg"},{"key":"929_CR33","doi-asserted-by":"crossref","unstructured":"Haddad MC, Clark DC, Sharif HS, al Shahed M, Aideyan O, Sammak BM (1992) MR, CT, and ultrasonography of splanchnic venous thrombosis. GastrointestRadiol 17:34\u201340","DOI":"10.1007\/BF01888505"},{"key":"929_CR34","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1160\/TH09-08-0606","volume":"03","author":"L Spiezia","year":"2010","unstructured":"Spiezia L, Rossetto V, Campello E, Gavasso S, Woodhams B, Tormene D, Simioni P (2010) Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis. Thromb Haemost 03:1188\u20131192","journal-title":"Thromb Haemost"},{"key":"929_CR35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1538-7836.2008.03221.x","volume":"1","author":"DA Tregouet","year":"2009","unstructured":"Tregouet DA, Schnabel R, Alessi MC, Godefroy T, Declerck PJ, Nicaud V, Munzel T, Bickel C, Rupprecht HJ, Lubos E, Zeller T, Juhan-Vague I, Blankenberg S, Tiret L, Morange PE (2009) Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study. J Thromb Haemost 1:49\u201357","journal-title":"J Thromb Haemost"},{"key":"929_CR36","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1160\/TH05-09-0620","volume":"95","author":"J Verd\u00fa","year":"2006","unstructured":"Verd\u00fa J, Pascual M, Benlloch S, Snachez J, Lucas J (2006) Thrombin activatable fibrinolysis inhibitor (TAFI) polymorphisms and plasma TAFI levels measured with an ELISA insensitive to isoforms in patients with venous thromboembolic disease (VTD). Thromb Haemost 95:585\u2013586","journal-title":"Thromb Haemost"},{"key":"929_CR37","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1182\/blood.V71.1.220.220","volume":"71","author":"PJ Declerck","year":"1988","unstructured":"Declerck PJ, Alessi MC, Verstreken M, Kruithof EK, Juhan-Vague I, Collen D (1988) Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 71:220\u2013225","journal-title":"Blood"},{"key":"929_CR38","doi-asserted-by":"crossref","unstructured":"Declerck PJ, Collen D (1990) Measurement of plasminogen activator inhibitor (PAI-1) in plasma with various monoclonal antibody-based enzyme-linked immunosorbent assays. Thromb Res Suppl X:3\u20139","DOI":"10.1016\/0049-3848(90)90373-K"},{"key":"929_CR39","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/jcp.47.3.214","volume":"47","author":"K Leiper","year":"1994","unstructured":"Leiper K, Croll A, Booth NA, Moore NR, Sinclair T, Bennett B (1994) Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease. J Clin Pathol 47:214\u2013217","journal-title":"J Clin Pathol"},{"key":"929_CR40","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.thromres.2007.07.008","volume":"121","author":"JW Ferguson","year":"2008","unstructured":"Ferguson JW, Helmy A, Ludlam C, Webb DJ, Hayes PC, Newby DC (2008) Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency. Thromb Res 121:675\u2013680","journal-title":"Thromb Res"},{"key":"929_CR41","doi-asserted-by":"crossref","unstructured":"Zhang D, Hao J, Yang N (2010) Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis. J Gastroenterol Hepatol l25:116\u2013121","DOI":"10.1111\/j.1440-1746.2009.05921.x"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-013-0929-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-013-0929-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-013-0929-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T00:16:56Z","timestamp":1595549816000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-013-0929-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,17]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["929"],"URL":"https:\/\/doi.org\/10.1007\/s11739-013-0929-7","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,17]]}}}